Schering-Plough pleads guilty to conspiracy, will sign CIA addendum
Pharma Compliance Alert, August 30, 2006
Schering-Plough says its Schering Sales Corporation subsidiary will plead guilty to one count of conspiracy to make false statements to the government. The guilty plea is part of an agreement with the U.S. Attorney's Office for the District of Massachusetts and the U.S. Department of Justice to settles a government investigation into the company's sales, marketing, and clinical trials practices and programs.
In connection with the settlement, Schering-Plough Corporation will sign an addendum to an existing corporate integrity agreement with the OIG. The company says the addendum won't affect its ongoing business with customers, including the federal government.
The subsidiary will also pay a criminal fine of $180 million, and Schering-Plough will pay $255 million to resolve civil aspects of the investigation.
Schering-Plough also pointed out in its statement about the settlement and guilty plea that the investigation began prior to the arrival of the company's new management, and said that "business integrity [is] at the center of its work."
Related Products
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- Capturing all necessary codes for IUD insertion and removal can be challenging
- QA:Coding multiple initial infusions
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Q&A tackles coding questions about injections and infusions
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- Case Management Monthly, June 2012
- Searched
